Biblio Discovery — Demo Discovery Service

11 results for "Mathieu Kuchenbuch"

Showing 1–11 · 1.61 seconds · RSS

  1. Journal Article

    3D figure of epilepsy syndromes

    Rima Nabbout; Mathieu Kuchenbuch; Paolo Tinuper et al.

    Epilepsia Open, Vol. 8 No. 1 · 2023 · English · DOAJ Scopus

    Abstract We propose an instructive figure that summarized the classification of epilepsy syndromes according to the 2022 report of the ILAE Task Force on Nosology and Definitions. Our aim is to present on the same figure different concepts such as the names of epilepsy syndromes, their extreme and…

  2. Journal Article

    Improving early diagnosis of rare diseases using Natural Language Processing in unstructured medical records: an illustration from Dravet syndrome

    Tommaso Lo Barco; Mathieu Kuchenbuch; Nicolas Garcelon et al.

    Orphanet Journal of Rare Diseases, Vol. 16 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Background The growing use of Electronic Health Records (EHRs) is promoting the application of data mining in health-care. A promising use of big data in this field is to develop models to support early diagnosis and to establish natural history. Dravet Syndrome (DS) is a rare…

  3. Journal Article

    Add‐on cannabidiol significantly decreases seizures in 3 patients with SYNGAP1 developmental and epileptic encephalopathy

    Mathieu Kuchenbuch; Gianluca D'Onofrio; Nicole Chemaly et al.

    Epilepsia Open, Vol. 5 No. 3 · 2020 · English · DOAJ Scopus

    Abstract Mutations in SYNGAP1 are associated with developmental delay, epilepsy, and autism spectrum disorder (ASD). Epilepsy is often drug‐resistant in this syndrome with frequent drop attacks. In a prospective study of add‐on cannabidiol (CBD), we identified three patients with SYNGAP1 mutations…

  4. Journal Article

    Trends in paediatric antiseizure-medication use and costs in France, 2014–2023: a nationwide population-based analysisResearch in context

    Rima Nabbout; Annaëlle Santilli; Louise Tyvaert et al.

    The Lancet Regional Health. Europe, Vol. 63 · 2026 · English · DOAJ Scopus

    Summary: Background: Epilepsy is the commonest chronic neurological disorder of childhood. In France, pregnancy-prevention rules and generic policies aim to improve safety and affordability of anti-seizure medications (ASM), but their paediatric impact is unknown. Tracking these patterns is key to…

  5. Journal Article

    Impact of the COVID-19 pandemic on the care of rare and undiagnosed diseases patients in France: a longitudinal population-based study

    Louis Soussand; Mathieu Kuchenbuch; Claude Messiaen et al.

    Orphanet Journal of Rare Diseases, Vol. 17 No. 1 · 2022 · English · DOAJ Scopus

    Abstract Background Preliminary data suggest that COVID-19 pandemic has generated a switch from face-to-face to remote care for individuals with chronic diseases. However, few data are available for rare and undiagnosed diseases (RUDs). We aimed to assess the impact of the COVID-19 pandemic on the…

  6. Journal Article Full text

    Methodological insights from the EPISTOP trial to designing clinical trials in rare diseases-A secondary analysis of a randomized clinical trial.

    Stephanie Wied; Ralf-Dieter Hilgers; Nicole Heussen et al.

    PLoS ONE, Vol. 19 No. 12 · 2024 · English · DOAJ Scopus

    BackgroundIn clinical research, the most appropriate way to assess the effect of an intervention is to conduct a randomized controlled trial (RCT). In the field of rare diseases, conducting an RCT is challenging, resulting in a low rate of clinical trials, with a high frequency of early termination…

    Also available at: PLOS

  7. Journal Article

    Slow Titration of Cannabidiol Add-On in Drug-Resistant Epilepsies Can Improve Safety With Maintained Efficacy in an Open-Label Study

    Gianluca D'Onofrio; Mathieu Kuchenbuch; Caroline Hachon-Le Camus et al.

    Frontiers in Neurology, Vol. 11 · 2020 · English · DOAJ Scopus

    Objective: To assess adverse events (AEs) and efficacy of add-on cannabidiol (CBD) with a slower titration protocol in pediatric clinical practice.Methods: We conducted a prospective, open-label, multicenter study in seven French reference centers for rare epilepsies. Patients had slow titration to…

  8. Journal Article

    A European pilot study in Dravet Syndrome to delineate what really matters for the patients and families

    Nicole Chemaly; Mathieu Kuchenbuch; Théo Teng et al.

    Epilepsia Open, Vol. 9 No. 1 · 2024 · English · DOAJ Scopus

    Abstract We aimed to identify caregivers' opinions on the outcome measures that matter in clinical trials in individuals with Dravet syndrome (DS). We conducted a prospective European multicenter study based on an 11 closed questions survey developed by the French reference center for rare…

  9. Journal Article

    Istore: a project on innovative statistical methodologies to improve rare diseases clinical trials in limited populations

    Stefanie Schoenen; Johan Verbeeck; Lukas Koletzko et al.

    Orphanet Journal of Rare Diseases, Vol. 19 No. 1 · 2024 · English · DOAJ Scopus

    Abstract Background The conduct of rare disease clinical trials is still hampered by methodological problems. The number of patients suffering from a rare condition is variable, but may be very small and unfortunately statistical problems for small and finite populations have received less…

  10. Journal Article

    Auditory evoked delta brushes involve stimulus-specific cortical networks in preterm infants

    Anna Kaminska; Dorothée Arzounian; Victor Delattre et al.

    iScience, Vol. 28 No. 5 · 2025 · English · DOAJ Scopus

    Summary: During the third trimester of gestation in humans, the auditory cortex displays spontaneous and auditory-evoked EEG patterns of intermittent local oscillatory activity nested in delta waves – delta brushes (DBs). To test whether the spatiotemporal dynamics of evoked DBs depends on stimulus…